RCAT Latest Quarter's Earnings
| Announce Date | 08/14/2025 |
| EPS Normalized Actual | $-0.14545 (Miss by $-0.03045) |
| EPS GAAP Actual | $-0.14545 (Miss by $-0.03045) |
| Revenue Actual | $0.00321858B |
| Revenue Surprise | Beat by $3.21858M |
Upcoming Quarter's Earnings
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
Annual EPS Estimate
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Apr 2027 | 0.28 | 35.79 | 0.28 | 0.28 | 1 |
| Apr 2026 | 0.08 | 125.25 | 0.06073012 | 0.09926988 | 1 |
Quarterly EPS History
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -0.15 | -0.15 | 0.00321858B | -96.03% | 3.22M |
| FQ1 2025 (Mar 2025) | -0.27 | -0.27 | 0.00162966B | -258.84% | 1.63M |
| FQ4 2024 (Oct 2024) | 0 | 0 | 0B | -INF% | 0M |
| FQ3 2024 (Jul 2024) | -0.17 | -0.17 | 0.00277654B | 37.04% | 2.78M |
| FQ2 2024 (Apr 2024) | -0.0952 | -0.0952 | 0.00630945B | 65.05% | 6.31M |
| FQ1 2024 (Jan 2024) | -0.0986 | -0.0986 | 0.00584793B | 100% | 5.85M |
| FQ3 2023 (Jul 2023) | -0.11 | -0.11 | 0.00174813B | 100% | 1.75M |
| FQ4 2023 (Oct 2023) | -0.1 | -0.1 | 0.00393087B | 100% | 3.93M |
Quarterly Estimates Summary
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Consensus EPS Estimates
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (May 2027) | 0.1 | -- | 0.1 | 0.1 | 1 |
| FQ1 2027 (Jan 2027) | 0.09 | -- | 0.09 | 0.09 | 1 |
| FQ4 2026 (Oct 2026) | 0.05 | -- | 0.05 | 0.05 | 1 |
| FQ3 2026 (Jul 2026) | 0.03 | -- | 0.03 | 0.03 | 1 |
| FQ2 2026 (May 2026) | 0.09 | 266.67 | 0.09 | 0.09 | 1 |
| FQ1 2026 (Jan 2026) | 0.06 | 550 | 0.06 | 0.06 | 1 |
| FQ4 2025 (Oct 2025) | -0.03 | -- | -0.03 | -0.03 | 1 |
Consensus Revenue Estimates
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (May 2027) | 0.06B | -- | 0.06B | 0.06B | 1 |
| FQ1 2027 (Jan 2027) | 0.05B | -- | 0.05B | 0.05B | 1 |
| FQ4 2026 (Oct 2026) | 0.05B | -- | 0.05B | 0.05B | 1 |
| FQ3 2026 (Jul 2026) | 0.05B | -- | 0.05B | 0.05B | 1 |
| FQ2 2026 (May 2026) | 0.04B | 90.91 | 0.04B | 0.04B | 1 |
| FQ1 2026 (Jan 2026) | 0.03B | 94.69 | 0.03B | 0.03B | 1 |
| FQ4 2025 (Oct 2025) | 0.02B | -- | 0.02B | 0.02B | 1 |
Quarterly Estimates Revisions
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Consensus EPS Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Consensus Revenue Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Earnings Surprise Summary
EPS # of Beats
0
EPS # of Misses
7
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
Earnings Surprise (EPS) - Actual vs Consensus
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -0.15 | -0.15 | 100% | |
| FQ1 2025 (Mar 2025) | -0.27 | -0.27 | 100% | |
| FQ4 2024 (Oct 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Jul 2024) | -0.17 | -0.17 | 100% | |
| FQ2 2024 (Apr 2024) | -0.0952 | -0.0952 | 100% | |
| FQ1 2024 (Jan 2024) | -0.0986 | -0.0986 | 100% | |
| FQ3 2023 (Jul 2023) | -0.11 | -0.11 | 100% | |
| FQ4 2023 (Oct 2023) | -0.1 | -0.1 | 100% |
Revenue Surprise - Actual vs Consensus
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0B | $0B | $3.22M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0B | $1.63M | 100% |
| FQ4 2024 (Oct 2024) | $0B | $0B | $0M | NAN% |
| FQ3 2024 (Jul 2024) | $0B | $0B | $2.78M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $0.01B | $6.31M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $0.01B | $5.85M | 100% |
| FQ3 2023 (Jul 2023) | $0B | $0B | $1.75M | 100% |
| FQ4 2023 (Oct 2023) | $0B | $0B | $3.93M | 100% |
RCAT Ratings Summary
RCAT Quant Ranking
